Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series - Top-Institutions - MDSpire

Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series

  • By

  • Ioannis Vasilikos

  • Roland Roelz

  • Christoph Scholz

  • Boris Mizaikoff

  • Katerina Argiti

  • Watzlawick Ralf

  • Georgios-Christos Giagkos

  • Evangelos M. Fragkakis

  • Shahram Ghanaati

  • Jürgen Beck

  • Ulrich Hubbe

  • August 24, 2021

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Spine Surgery
    • Regenerative Medicine
    • Infectious Diseases

  • #2

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Neurosurgery
    • Orthopedic Surgery
    • Regenerative Medicine

  • #3

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Orthopedic Surgery
    • Spine Surgery
    • Infectious Disease

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Neurosurgery
    • Plastic Surgery
    • Regenerative Medicine

  • #5

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Orthopedic Surgery
    • Neurosurgery
    • Regenerative Medicine

Original Source(s)

Autologous platelet-rich fibrin (PRF) augmentation as an add-on therapy in deep surgical site infections (dSSIs) after instrumented spinal surgery: preliminary results of a single institution case series

  • by Ioannis Vasilikos, Roland Roelz, Christoph Scholz, Boris Mizaikoff, Katerina Argiti, Watzlawick Ralf, Georgios-Christos Giagkos, Evangelos M. Fragkakis, Shahram Ghanaati, Jürgen Beck, Ulrich Hubbe

  • August 24, 2021

Related Content

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

The antimicrobial potential of the secretome from Wharton’s jelly mesenchymal stem cells in the context of regenerative medicine: an in vitro study